Publikationen in Zusammenarbeit mit Forschern von Centro Nacional de Investigaciones Oncológicas (24)

2023

  1. Improved Sensitivity in BRAFV600E Detection in Combined Tissue and Extracellular Vesicle-Based Liquid Biopsy in Melanoma

    Journal of Investigative Dermatology, Vol. 143, Núm. 8, pp. 1606-1610

2021

  1. Live imaging of neolymphangiogenesis identifies acute antimetastatic roles of dsRNA mimics

    EMBO Molecular Medicine, Vol. 13, Núm. 12

2020

  1. Midkine rewires the melanoma microenvironment toward a tolerogenic and immune-resistant state

    Nature Medicine, Vol. 26, Núm. 12, pp. 1865-1877

2019

  1. Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and BRAFV600E mutation

    Journal of Experimental Medicine, Vol. 216, Núm. 5, pp. 1061-1070

  2. p62/SQSTM1 Fuels Melanoma Progression by Opposing mRNA Decay of a Selective Set of Pro-metastatic Factors

    Cancer Cell, Vol. 35, Núm. 1, pp. 46-63.e10

2017

  1. DEK oncogene is overexpressed during melanoma progression

    Pigment Cell and Melanoma Research, Vol. 30, Núm. 2, pp. 194-202

  2. Systems analysis identifies melanoma-enriched pro-oncogenic networks controlled by the RNA binding protein CELF1

    Nature Communications, Vol. 8, Núm. 1

  3. Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine

    Nature, Vol. 546, Núm. 7660, pp. 676-680

2016

  1. Lineage-specific roles of the cytoplasmic polyadenylation factor CPEB4 in the regulation of melanoma drivers

    Nature Communications, Vol. 7

2014

  1. PIM kinases as potential therapeutic targets in a subset of peripheral T cell lymphoma cases

    PLoS ONE, Vol. 9, Núm. 11

  2. PLCG1 mutations in cutaneous T-cell lymphomas

    Blood, Vol. 123, Núm. 13, pp. 2034-2043

  3. RAB7 Controls Melanoma Progression by Exploiting a Lineage-Specific Wiring of the Endolysosomal Pathway

    Cancer Cell, Vol. 26, Núm. 1, pp. 61-76

2013

  1. MicroRNAs as prognostic markers in indolent primary cutaneous B-cell lymphoma

    Modern Pathology, Vol. 26, Núm. 2, pp. 171-181

  2. NIK controls classical and alternative NF-κB activation and is necessary for the survival of human T-cell lymphoma cells

    Clinical Cancer Research, Vol. 19, Núm. 9, pp. 2319-2330

  3. Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas

    Haematologica, Vol. 98, Núm. 1, pp. 57-64

  4. TCR-γ expression in primary cutaneous T-cell lymphomas

    American Journal of Surgical Pathology, Vol. 37, Núm. 3, pp. 375-384

2011

  1. Primary cutaneous CD30 anaplastic large-cell lymphomas show a heterogeneous genomic profile: An oligonucleotide arrayCGH approach

    Journal of Investigative Dermatology

2010

  1. Oligonucleotide array-cgh identifies genomic subgroups and prognostic markers for tumor stage mycosis fungoides

    Journal of Investigative Dermatology, Vol. 130, Núm. 4, pp. 1126-1135

  2. Vorinostat interferes with the signaling transduction pathway of T-cell receptor and synergizes with phosphoinositide-3 kinase inhibitors in cutaneous T-cell lymphoma

    Haematologica, Vol. 95, Núm. 4, pp. 613-621

2009

  1. Psoralen plus ultraviolet A ± interferon-α treatment resistance in mycosis fungoides: The role of tumour microenvironment, nuclear transcription factor-κB and T-cell receptor pathways

    British Journal of Dermatology, Vol. 160, Núm. 1, pp. 92-102